Literature DB >> 15753008

The epidemiology of human papillomavirus infections.

Janet G Baseman1, Laura A Koutsky.   

Abstract

Infection with oncogenic human papillomavirus (HPV) types is a necessary cause of cervical cancer, the second most frequently occurring cancer in women worldwide. Rates of acquisition of HPV are high, particularly among sexually active young adults. Reported estimates of incident HPV infection among initially negative women have reached as high as 60% over a 5-year follow-up period. In this article, we review the epidemiology of HPV infection. In addition to estimates of disease frequency, we highlight risk factors for HPV infection, including the number of lifetime sex partners, which is the most salient risk factor. We discuss significant issues surrounding the natural history of HPV infection, including viral persistence versus clearance, immune response, development of lesions and development of cancer. Finally, we discuss strategies for preventing HPV infection.

Entities:  

Mesh:

Year:  2005        PMID: 15753008     DOI: 10.1016/j.jcv.2004.12.008

Source DB:  PubMed          Journal:  J Clin Virol        ISSN: 1386-6532            Impact factor:   3.168


  184 in total

1.  Distribution of CCND1 A870G polymorphism in patients with advanced uterine cervical carcinoma.

Authors:  Teresa Warchoł; Lukasz Kruszyna; Margarita Lianeri; Andrzej Roszak; Paweł P Jagodziński
Journal:  Pathol Oncol Res       Date:  2010-08-03       Impact factor: 3.201

Review 2.  Vaccines to prevent infections by oncoviruses.

Authors:  John T Schiller; Douglas R Lowy
Journal:  Annu Rev Microbiol       Date:  2010       Impact factor: 15.500

3.  Inhibition of human papillomavirus DNA replication by an E1-derived p80/UAF1-binding peptide.

Authors:  Michaël Lehoux; Amélie Fradet-Turcotte; Mathieu Lussier-Price; James G Omichinski; Jacques Archambault
Journal:  J Virol       Date:  2012-01-25       Impact factor: 5.103

4.  Trends in the Prevalence of Anogenital Warts Among Patients at Sexually Transmitted Disease Clinics-Sexually Transmitted Disease Surveillance Network, United States, 2010-2016.

Authors:  Laura M Mann; Eloisa Llata; Elaine W Flagg; Jaeyoung Hong; Lenore Asbel; Juli Carlos-Henderson; Roxanne P Kerani; Robert Kohn; Preeti Pathela; Christina Schumacher; Elizabeth A Torrone
Journal:  J Infect Dis       Date:  2019-04-16       Impact factor: 5.226

5.  Human papillomavirus infection and reinfection in adult women: the role of sexual activity and natural immunity.

Authors:  Helen Trottier; Silvaneide Ferreira; Patricia Thomann; Maria C Costa; Joao S Sobrinho; José Carlos M Prado; Thomas E Rohan; Luisa L Villa; Eduardo L Franco
Journal:  Cancer Res       Date:  2010-10-26       Impact factor: 12.701

6.  Sexually transmitted diseases in the USA: temporal trends.

Authors:  Sevgi O Aral; Kevin A Fenton; King K Holmes
Journal:  Sex Transm Infect       Date:  2007-07       Impact factor: 3.519

7.  Determinants of newly detected human papillomavirus infection in HIV-infected and HIV-uninfected injection drug using women.

Authors:  Darcy F Phelan; Stephen J Gange; Linda Ahdieh-Grant; Shruti H Mehta; Gregory D Kirk; Keerti Shah; Patti Gravitt
Journal:  Sex Transm Dis       Date:  2009-03       Impact factor: 2.830

8.  Human papillomavirus in high-grade cervical lesions: Austrian data of a European multicentre study.

Authors:  Lucia Rössler; Olaf Reich; Reinhard Horvat; Sabrina Collas de Souza; Katsyarina Holl; Elmar A Joura
Journal:  Wien Klin Wochenschr       Date:  2013-09-17       Impact factor: 1.704

9.  Karyopherin beta3: a new cellular target for the HPV-16 E5 oncoprotein.

Authors:  Ewa Krawczyk; John A Hanover; Richard Schlegel; Frank A Suprynowicz
Journal:  Biochem Biophys Res Commun       Date:  2008-05-01       Impact factor: 3.575

10.  Development and evaluation of a liquid bead microarray assay for genotyping genital human papillomaviruses.

Authors:  Qinghua Feng; Stephen Cherne; Rachel L Winer; Akhila Balasubramanian; Shu-Kuang Lee; Stephen E Hawes; Nancy B Kiviat; Laura A Koutsky
Journal:  J Clin Microbiol       Date:  2009-01-14       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.